Orphinic ScientificS.A.Active
Research and experimental development on biotechnology
KRS: 0000919083 NIP: 5213877066 REGON: 38440451800000
Overview
Registry date
2021-09-03
Share capital
$136,707.43
Activity description
Orphinic Scientific is a biopharma holding that focuses on the clinical development of innovative therapeutics, MedTech, and e-Health projects. The company actively manages a portfolio of promising biotech projects, including a potent analgesic formulation and a first-in-class gene therapy for rare ischemic limb diseases. They also partner with large pharmaceutical players to verify research hypotheses and facilitate project transactions.
Registered address
Ul. Stanisława Żaryna 2B, 02-593 Warszawa, Poland
Website
orphinic.comWebsite active
Email
Email address current
Electronic delivery address
AE:PL-12967-28260-CUWDC-20
Industry
| Name | Code |
|---|---|
Research and experimental development on biotechnologyPrimary | 72.11.Z |
Other credit granting | 64.92.Z |
Other financial service activities, except insurance and pension funding not elsewhere | 64.99.Z |
Business and other management consultancy activities | 70.22.Z |
Other human health activities not elsewhere classified | 86.90.E |
Bank accounts
Registered as a VAT taxpayer on 2020-09-01.Active
- 03 2490 0005 0000 4600 8737 7972
- 68 2490 0005 0000 4530 3477 6850
- 95 2490 0005 0000 4600 1201 8277
Authorized Representatives
Ownership
Subsidiaries
| Name | Shares | Share value | % in company | |
|---|---|---|---|---|
| VM1sp. z o.o. | 150 | 2,025.93 USD | 100% | |
| Virtual Monitor Systemssp. z o.o. | 94 | 1,269.58 USD | 89.5238% | |
| Clinical Servantsp. z o.o. | 76 | 1,026.47 USD | 76% | |
| Tramagsp. z o.o. | 199 | 2,687.74 USD | 59.0504% | |
| Bioxymasp. z o.o. | 62 | 837.39 USD | 55.8559% |
Competitors
| Name | Revenue | Website | |
|---|---|---|---|
| GenomtecS.A. | $931,086.83 | genomtec.com | |
| GenxoneS.A. | $542,750.94 | genxone.eu | |
| BiottsS.A. | $372,115.60 | biotts.com | |
| Medicofarma BiotechS.A. | $330,956.61 | medicofarmabiotech.pl | |
| Frontline BiosciencesS.A. | $219,186.29 | frontlinebiosciences.com | |
| FcbiotechS.A. | $148,945.77 | fcbiotech.pl | |
| UveraS.A. | $155,384.29 | uvera.eu | |
| PellicarnosS.A. | $135,043.43 | pellicarnos.com | |
| IntelliseqS.A. | $111,419.60 | intelliseq.pl | |
| WPD PharmaceuticalsS.A. | $87,561.70 | wpdpharmaceuticals.pl/contact/wpdsa/ |
Change history
| Event | Details | Date | |
|---|---|---|---|
| Address change | Ul. Postępu 21b, 02-676, Warszawa → Ul. Stanisława Żaryna 2b, 02-593, Warszawa | 2026-04-09 | |
| Share capital change | 440562.80 PLN → 506090.90 PLN | 2026-04-09 |
FAQ
Last updated: 2026-04-09